NEXUS

Chang Robotics and Matthews Automation Deliver Next-Level Turnkey Automation Solutions

Retrieved on: 
火曜日, 4月 30, 2024
Automation, Investment, Robotics, Software, Partnership, NEXUS, Engineering, Warehouse execution system, MES, Airport, WMS, WES, Health, Projection, Warehouse

JACKSONVILLE, Fla., April 30, 2024 /PRNewswire/ -- Chang Robotics, a leading innovator in advanced manufacturing solutions, today announced a strategic partnership with Matthews Automation Solutions, a global leader in automation and execution systems.

Key Points: 
  • JACKSONVILLE, Fla., April 30, 2024 /PRNewswire/ -- Chang Robotics, a leading innovator in advanced manufacturing solutions, today announced a strategic partnership with Matthews Automation Solutions, a global leader in automation and execution systems.
  • Chang Robotics' expertise in customized engineering solutions along with Matthews's industry-leading software, picking solutions, and robotic solutions integration empowers businesses who are leaning into autonomous systems to enhance worker productivity.
  • Chang Robotics' expertise in robotics integration will provide customized manufacturing and healthcare solutions to work alongside the team in place.
  • "Matthews Automation is excited to join forces with Chang Robotics," said Jack Hampshire, Vice-President Commercial at Matthews Automation.

Creta Announces Yoshiki Okamoto's New Game Title "Project Creta" on 8th of April at Creta's Web3 GameFi Incubation Program NEXUS

Retrieved on: 
火曜日, 4月 16, 2024
Metaverse, Nexus, Street Fighter II, League of Legends, Gentlemen's agreement, NEXUS, Monster Strike, Science fiction, League, Esports, CBT, Confidentiality, Yoshiki Okamoto, Video game

This project is the first to be launched under CRETA NEXUS, an incubation program for projects developing entertainment content.

Key Points: 
  • This project is the first to be launched under CRETA NEXUS, an incubation program for projects developing entertainment content.
  • On April 8th, a highly anticipated event took place in Tokyo where game designer Yoshiki Okamoto presented "Project Creta," which will be launched on CRETA NEXUS.
  • The attendees include participants of the "Project Creta" presentation, renowned game creators and developers, game media representatives, game influencers, Web3 influencers, as well as Creta supporters.
  • "I recently came across the NEXUS program offered by CRETA and was intrigued by this unique initiative within the cryptocurrency platform.

Silverado Memory Care Nexus Program Honored by Argentum With “Best of the Best” Award

Retrieved on: 
火曜日, 4月 30, 2024
Seniors, Practice Management, Nursing, Managed Care, General Health, Health, Consumer, Other Health, Nexus, Argentum, NEXUS, Dementia, GNP, Senior, RN, Amnesia

Silverado Memory Care , a leading provider in senior living and memory care, is proud to announce its Nexus Program designed to preserve cognitive functioning and slow the progression of dementia, has been recognized with Argentum’s “Best of the Best” Award, for its unique approach to supporting an active, brain-healthy lifestyle for individuals living with the early stages of dementia.

Key Points: 
  • Silverado Memory Care , a leading provider in senior living and memory care, is proud to announce its Nexus Program designed to preserve cognitive functioning and slow the progression of dementia, has been recognized with Argentum’s “Best of the Best” Award, for its unique approach to supporting an active, brain-healthy lifestyle for individuals living with the early stages of dementia.
  • “It’s exciting for us to be recognized alongside fellow industry leaders who are paving the way for the future of senior living,” said Loren Shook, Chief Executive Officer and Chairman of Silverado .
  • The “Best of the Best” Award recognizes innovative new programs and services that are working to improve the future of, or solve particular challenges within, senior living.
  • For more information about Silverado and the Nexus Program, visit www.silverado.com/nexus-at-silverado/ .

Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
木曜日, 3月 21, 2024
Research, Ulcerative colitis, ECCO, LTE, ACG, Patient, UC, Journal, Biomarker, NEXUS, Wind, Insurance, Abstract, American College, Clinical trial, Safety, Pharmacokinetics, Poster, NLRX1, European, PLXDC2, Pharmaceutical industry

NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP) (“Landos” or “the Company”), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today provided a business update and reported financial results for the fourth quarter and the full year ended December 31, 2023.

Key Points: 
  • NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP) (“Landos” or “the Company”), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today provided a business update and reported financial results for the fourth quarter and the full year ended December 31, 2023.
  • Top-line results are planned for the fourth quarter of 2024.
  • Research and development expenses were $3.1 million for the fourth quarter of 2023, compared to $3.4 million for the fourth quarter of 2022.
  • General and administrative expenses were $3.5 million for the fourth quarter of 2023, compared to $3.1 million for the fourth quarter of 2022.

The CBSA and U.S. CBP provide an update on the NEXUS program

Retrieved on: 
火曜日, 4月 2, 2024
Telephone, Transport, CBSA, Introduction, Interview, Crime, NEXUS, CBP, Airport, Canada Border Services Agency, Television

The current fee, set over 20 years ago, no longer covers the cost of the program.

Key Points: 
  • The current fee, set over 20 years ago, no longer covers the cost of the program.
  • The new fee would reflect more accurately the cost of administrating the program and the investment required for future program improvements, including technology and infrastructure enhancements.
  • The proposed increase would help keep up with the high demand for the program and continue to improve NEXUS.
  • The NEXUS program currently has over 1.8 million members, with the majority of members being Canadian.

NEXEN TIRE awarded two main prizes at iF Design Awards 2024

Retrieved on: 
火曜日, 3月 5, 2024
Nexen Tire, Sejong University, Communication, NEXUS, History, Movement, Student

SEOUL, South Korea, March 05, 2024 (GLOBE NEWSWIRE) -- NEXEN TIRE, a leading global tire manufacturer, today announced that two works, NEXERA and NEXUS, have won the main prize in the communication design category of Germany's iF Design Awards 2024.

Key Points: 
  • SEOUL, South Korea, March 05, 2024 (GLOBE NEWSWIRE) -- NEXEN TIRE, a leading global tire manufacturer, today announced that two works, NEXERA and NEXUS, have won the main prize in the communication design category of Germany's iF Design Awards 2024.
  • The works awarded by NEXEN Tire are the result of an industry-academic collaboration with Sejong University and its students from the design innovation major.
  • The visual design works that have been reinterpreted and released are based on NEXEN Tire's design philosophy, "Ultimate Sensual, Timeless Movement."
  • The iF International Forum Design GmbH is a long-standing independent design organization based in Hanover, Germany, that annually awards the iF Design Award for the best design results.

PEI Group Unveils NEXUS 2024: The Premier Private Investment Summit

Retrieved on: 
月曜日, 2月 12, 2024
Senior, Intelligence, GP, Golf, Private Equity International, The Carlyle Group, Orlando Bravo, Oaktree Capital Management, CalSTRS, NEXUS, LP record, Partner (business rank), Thoma Bravo, Publication, PEI

NEW YORK, Feb. 12, 2024 /PRNewswire-PRWeb/ -- PEI Group, the leading source of intelligence for the private investment industry, is pleased to announce NEXUS 2024, the inaugural installment of an annual summit that aims to recast the conversation around and within private equity and connect limited partners responsible for more than $30 trillion with top-tier general partners.

Key Points: 
  • "With over 500 influential participants, including top investors, managers, and service providers in the asset class, NEXUS 2024 is a must-attend event for anyone in the private equity industry," said William O'Conor, PEI's U.S.
  • NEXUS 2024, which takes place March 6-8, 2024, in Orlando, Florida, is supported by three key industry publications published by PEI Group: Buyouts , the leading authority in U.S. mid-market private equity; PE Hub , the premium intelligence service covering private equity deal-making in North America, and Private Equity International , the only global publication with a primary focus on the relationship between private equity investors and fund managers.
  • The event is a natural extension of PEI Group's commitment to advancing the broad private equity community.
  • "2024 represents a pivotal year for private equity, and investors are at a critical juncture with respect to allocations and emerging opportunities.

Dealer Alchemist Announces Strategic Acquisition of AutoGo to Enhance its Automotive Digital Solutions

Retrieved on: 
木曜日, 2月 1, 2024
NEXUS, Advertising, Ecosystem, Marketing, Acquisition, Car dealership

LONE TREE, Colo., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Dealer Alchemist , a pioneer in automotive marketing solutions, is thrilled to announce the acquisition of AutoGo (formerly Dealer Venom), a leader in advanced automotive website platforms.

Key Points: 
  • LONE TREE, Colo., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Dealer Alchemist , a pioneer in automotive marketing solutions, is thrilled to announce the acquisition of AutoGo (formerly Dealer Venom), a leader in advanced automotive website platforms.
  • This acquisition marks a significant milestone in Dealer Alchemist's mission to revolutionize digital advertising in the automotive industry.
  • This combined platform will now be a pivotal offering for Dealer Alchemist and AutoGo clients, promising to elevate their digital presence and operational effectiveness.
  • "This acquisition is a game-changer for Dealer Alchemist and our dealers," said Shean Kirin, CEO of Dealer Alchemist.

Endospan Releases Early TRIOMPHE IDE Study Results at Society of Thoracic Surgeons

Retrieved on: 
火曜日, 1月 30, 2024
Surgery, Medical Devices, Clinical Trials, Health Technology, Cardiology, Biotechnology, Health, General Health, Oncology, Multimedia, ICU, Surgeon, Mortality, Hypothermia, Trial of the century, Kidney, Disease, NEXUS, Society, Patient, Safety, Hospital, Paraplegia, IDE

As a notice of availability to educate potential referring physicians about the TRIOMPHE study, Endospan shared the 30-day results of the first 22 patients enrolled in the TRIOMPHE IDE study in a Late-Breaking presentation at the 60th Annual Meeting of the Society of Thoracic Surgeons in San Antonio, Texas this past weekend.

Key Points: 
  • As a notice of availability to educate potential referring physicians about the TRIOMPHE study, Endospan shared the 30-day results of the first 22 patients enrolled in the TRIOMPHE IDE study in a Late-Breaking presentation at the 60th Annual Meeting of the Society of Thoracic Surgeons in San Antonio, Texas this past weekend.
  • TRIOMPHE is a multi-arm, multi-center, non-randomized, prospective, clinical study to evaluate the safety and effectiveness of NEXUS® in treating thoracic aortic lesions involving the aortic arch.
  • “NEXUS is designed for total endovascular arch repair to address the specific challenges of the aortic arch anatomy,” said Kevin Mayberry, CEO.
  • “We are pleased to see that this early data aligns with the results achieved during the EU clinical study.

AAMI and FDA Co-Sponsor Medtech Conference, ‘AAMI and FDA neXus'

Retrieved on: 
月曜日, 1月 8, 2024
Nexus, Conference, University of Utah, Food, Johnson & Johnson, FDA, NEXUS, ISC, QSR, AAMI, ASCA, University, Omni Shoreham Hotel, Sterilization, Device, CDRH, Ethylene oxide, ISO, USB On-The-Go, Intuitive Surgical, Medical device

The conference will feature a wealth of FDA experts alongside industry members and will focus on the latest information on medical device regulations and standards.

Key Points: 
  • The conference will feature a wealth of FDA experts alongside industry members and will focus on the latest information on medical device regulations and standards.
  • Real-world evidence and medical device safety, presented by Daniel Caños, director of the Office of Clinical Evidence and Analysis at CDRH.
  • The FDA case for quality, delivered by Francisco Vicenty, FDA consumer safety officer.
  • Development, adoption, and now application of standards, neXus covers it all.”
    Those interested in attending can find registration for the AAMI FDA neXus here .